Imatinib Mesylate Tablet, Film Coated
Product Images NDC 48433-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 48433-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imatinib Mesylate Structural Formula (Image 01)

FDA Label Image

Progression Free Survival (itt Principle) (Image 02)

FDA Label Image

Time To Progression To Ap Or Bc (itt Principle) (Image 03)

FDA Label Image

Study 1 Recurrence-free Survival (itt Population) (Image 04)

Study 1 Recurrence-free Survival (itt Population) (Image 04)
This text appears to describe information related to survival rates and probabilities of recurrence in a medical or health-related context. It mentions percentages and numbers which could be indicating survival rates over certain periods of time. The text also touches upon the concept of recurrence. It provides numerical data which may be used for analysis or decision-making regarding treatment and prognosis.*
FDA Label Image

Study 2 Recurrence-free Survival (itt Population) (Image 05)

Study 2 Recurrence-free Survival (itt Population) (Image 05)
Not available.*
FDA Label Image

Study 2 Overall Survival (itt Population) (Image 06)

FDA Label Image

Imatinib Mesylate Tablets 100 mg Unit Carton Label (Image 07)

Imatinib Mesylate Tablets 100 mg Unit Carton Label (Image 07)
This text provides information about Imatinib Mesylate tablets in 100 mg strength with NDC 48433-049-03. The tablets are available as a prescription-only medication in packages of 30 tablets (3x10). The recommended storage temperature is between 20°C to 25°C, with protection from light. The manufacturer is not clearly indicated.*
FDA Label Image

Unit Carton (Image 08)

Unit Carton (Image 08)
This text is not readable.*
FDA Label Image

Imatinib Mesylate Tablets 400 mg Unit Carton Label (Image 09)

Imatinib Mesylate Tablets 400 mg Unit Carton Label (Image 09)
This text contains information about Imatinib Mesylate tablets with NDC 48433-050-03. It includes dosage instructions and storage recommendations to protect the tablets from moisture. Additionally, it mentions the manufacturer label "MtainGamary" and the presence of the USP Controlled room temperature on the packaging.*
FDA Label Image

Unit Carton (Image 10)

Unit Carton (Image 10)
This is a product package for a glucose item that is not heat resistant and is intended for institutional use. It is important to keep it away from children and store it in a cool, dry place. The package contains information on the amount of product and the expiration date. Distributed by Safecor Health LLC in Rockford, IL, USA. Contact Safecor Health Company at 1-800-447-1006 or SafecorHealth.com for more information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.